QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=7FB9896AAF1D981CF351FB86FA930E4D;jsessionid=17F673886F3B576E67C93F0E584B578D;jsessionid=FB449F36D7AF656CBCD4D662895F8CB9;jsessionid=A886C914B7D209AF93ED0ABD70C83096;jsessionid=E4EAC9728DDC7D6B71253F8E308762DC (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=7FB9896AAF1D981CF351FB86FA930E4D;jsessionid=17F673886F3B576E67C93F0E584B578D;jsessionid=FB449F36D7AF656CBCD4D662895F8CB9;jsessionid=A886C914B7D209AF93ED0ABD70C83096;jsessionid=E4EAC9728DDC7D6B71253F8E308762DC